Cargando…

Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN‐null triple negative breast cancer

Triple‐negative breast cancer (TNBC) has poorer prognosis compared to other types of breast cancers due to the lack of effective therapies and markers for patient stratification. Loss of PTEN tumor suppressor gene expression is a frequent event in TNBC, resulting in over‐activation of the PI 3‐kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zecchin, Davide, Moore, Christopher, Michailidis, Fanourios, Horswell, Stuart, Rana, Sareena, Howell, Michael, Downward, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411640/ https://www.ncbi.nlm.nih.gov/pubmed/32672423 http://dx.doi.org/10.15252/emmm.202011987

Ejemplares similares

Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
por: Qi, Zhi, et al.
Publicado: (2022)

Disruption of the Interaction of RAS with PI 3-Kinase Induces Regression of EGFR-Mutant-Driven Lung Cancer
por: Murillo, Miguel M., et al.
Publicado: (2018)

Precision Targeting of pten-Null Triple-Negative Breast Tumors Guided by Electrophilic Metabolite Sensing
por: Liu, Xuyu, et al.
Publicado: (2020)

WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2020)

Central Role of the EGF Receptor in Neurometabolic Aging
por: Siddiqui, Sana, et al.
Publicado: (2012)

Local signaling by the EGF receptor
por: Kempiak, Stephan J., et al.
Publicado: (2003)

Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2021)

An unexpected role for PI4,5P(2) in EGF receptor endosomal trafficking
por: Sun, Yue, et al.
Publicado: (2013)

Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity
Publicado: (1992)

Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway
por: Yang, Ruichuang, et al.
Publicado: (2021)

The EGF receptor is an actin-binding protein
Publicado: (1992)

EGF receptor ligands: recent advances
por: Singh, Bhuminder, et al.
Publicado: (2016)

Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor
Publicado: (1986)

Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor
por: Liu, Ning Sheng, et al.
Publicado: (2009)

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
por: Dunn, Shanade, et al.
Publicado: (2022)

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
por: Coelho, Matthew A., et al.
Publicado: (2017)

An ultrasensitive sorting mechanism for EGF Receptor Endocytosis
por: Schmidt-Glenewinkel, Hannah, et al.
Publicado: (2008)

The interactome of human EGF/ErbB receptors
por: Uetz, Peter, et al.
Publicado: (2006)

Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010)

EGF receptor trafficking: consequences for signaling and cancer
por: Tomas, Alejandra, et al.
Publicado: (2014)

Autophagy processes are dependent on EGF receptor signaling
por: De Iuliis, Vincenzo, et al.
Publicado: (2018)

Analyzing expression and phosphorylation of the EGF receptor in HNSCC
por: Kriegs, Malte, et al.
Publicado: (2019)

Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes
Publicado: (1996)

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor
por: Swindle, C. Scott, et al.
Publicado: (2001)

The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus
por: Korotkevych, Nataliia V., et al.
Publicado: (2015)

Activation of hepatic stellate cell in Pten null liver injury model
por: He, Lina, et al.
Publicado: (2016)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Prvanović, Mirjana, et al.
Publicado: (2021)

JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor
por: Zhang, Fu-quan, et al.
Publicado: (2015)

Silibinin Radiosensitizes EGF Receptor-knockdown Prostate Cancer Cells by Attenuating DNA Repair Pathways
por: Rajput, Mohit, et al.
Publicado: (2022)

Kinetics of binding, endocytosis, and recycling of EGF receptor mutants
Publicado: (1992)

Prognostic impact of EGF-receptor in papillary thyroid carcinoma.
por: Akslen, L. A., et al.
Publicado: (1993)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Mechanistic Insights into the Activation of Oncogenic Forms of EGF Receptor
por: Wang, Zhihong, et al.
Publicado: (2011)

Ligand regulation of a constitutively dimeric EGF receptor
por: Freed, Daniel M., et al.
Publicado: (2015)

Structural basis of the effect of activating mutations on the EGF receptor
por: Galdadas, Ioannis, et al.
Publicado: (2021)

EGF receptor modulates HEV entry in human hepatocytes
por: Schrader, Jil A., et al.
Publicado: (2023)

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors.
por: Kwok, T. T., et al.
Publicado: (1991)

Two-pore channels affect EGF receptor signaling by receptor trafficking and expression
por: Müller, Thomas, et al.
Publicado: (2021)

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
por: Degtyarev, Michael, et al.
Publicado: (2008)

Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer
por: Kappler, Christiana S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qkj0s7b87oeuun5ukoes8g8eua